Themed Partnerships for Detection
Healioscan collaborates with research institutions and technology partners to advance PAMLEE™ as a multimodal AI system for early cancer detection.
PAMLEE™ is undergoing structured validation initiatives in collaboration with Vanderbilt-affiliated research environments to assess performance, explainability, and clinical alignment.
Our AI cancer collaborations focus on responsibly advancing early detection through multimodal AI partnerships across academic, technology, and pharmaceutical domains.
Healioscan Collaborations: Advancing PAMLEE™ Oncology through academic, technology, and pharmaceutical partnerships.
Universities and medical research institutions
Clinical trials and validation studies
Peer-aligned research initiatives
AI infrastructure and compute platforms
Imaging and data pipeline partners
Secure deployment environments
Oncology research alignment
Biomarker and treatment pathway insights
Translational research support
Academic institutions supporting PAMLEE™ research, validation, and peer-aligned study frameworks.
Academic research flipbook (labs/trials/imaging)
Technology partners enabling secure AI infrastructure, imaging pipelines, and deployment scalability.
AI infrastructure / system architecture visuals
Pharmaceutical partnerships supporting translational research and oncology innovation using PAMLEE™.
Oncology research / molecular visuals
Our Customer Support team is always ready to help you with quick solutions and reliable assistance whenever you need it.
Ticket Support helps you report problems and track solutions easily through a dedicated support system.
Free Insight provides valuable information and expert guidance to help you make informed decisions.
